CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-24 | Szela Mary T Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-05-24 | Richards Christos Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-05-24 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-05-24 | Satvat Ali J. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-05-17 | Watler Peter K. Chief Technical Officer | Option exercise | +12,000 | $2.08 | $25K | 12,000 |
| 2016-05-17 | Watler Peter K. Chief Technical Officer | Sale | −12,000 | $20.00 | $240K | 0 |
| 2016-05-17 | Watler Peter K. Chief Technical Officer | Option exercise · Stock Option (right to buy) | −12,000 | 43,495 | ||
| 2016-05-11 | Lanfear Dennis M President and CEO | Grant or award · Stock Option (Right to Buy) | +323,889 | 323,889 | ||
| 2016-05-11 | Watler Peter K. Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +78,472 | 78,472 | ||
| 2016-05-11 | FINCK BARBARA K Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +78,472 | 78,472 | ||
| 2016-05-11 | Herman Alan C. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | −69,236 | 69,236 | ||
| 2016-05-11 | Viret Jean-Frederic Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +78,472 | 78,472 | ||
| 2016-05-02 | Watler Peter K. Chief Technical Officer | Option exercise | +1,493 | $2.08 | $3K | 1,493 |
| 2016-05-02 | Watler Peter K. Chief Technical Officer | Sale | −1,493 | $20.00 | $30K | 0 |
| 2016-05-02 | Watler Peter K. Chief Technical Officer | Option exercise · Stock Option (right to buy) | −1,493 | 55,495 | ||
| 2016-05-02 | Herman Alan C. Chief Scientific Officer | Sale | −3,698 | $19.13 | $71K | 207,167 |
| 2016-05-02 | Herman Alan C. Chief Scientific Officer | Sale | −552 | $19.63 | $11K | 206,615 |
| 2016-04-01 | Herman Alan C. Chief Scientific Officer | Sale | −3,273 | $21.20 | $69K | 211,842 |
| 2016-04-01 | Herman Alan C. Chief Scientific Officer | Sale | −977 | $21.89 | $21K | 210,865 |
| 2016-03-28 | Viret Jean-Frederic Chief Financial Officer | Option exercise | +400 | $13.50 | $5K | 400 |
Page 29 of 39 · 768 trades